Skip to main content
. 2018 Apr 21;25(5):653–660. doi: 10.1177/1352458518767327

Figure 4.

Figure 4.

Competition ELISA to measure neutralising antibodies. Sera BLT00139, BLT00143 and BUH00117 were obtained from CDMS patients, sera CIS 309, CIS 310, CIS 312 and CIS 313 from patients diagnosed with CIS and sera ON YB6, ON BG5, ON MF6 and ONWV1 from patients diagnosed with ON. PEG14, PEG16 and PEG17 are control sera.